- Report
- August 2024
- 220 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- March 2025
- 200 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- January 2025
- 170 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- October 2024
- 130 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2024
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2025
- 459 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 92 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- February 2025
- 120 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- February 2025
- 120 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- November 2024
- 100 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 162 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 246 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- March 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more